WELCOME · JUNE 18–19, 2026 · LANSDOWNE RESORT, LEESBURG VA

    Epilepsy Pipeline 2026.

    If we connected at the conference — welcome. Here's how Komori fits the work you do.

    Komori Care is a privacy-first contactless multimodal nocturnal monitoring platform built in partnership with UVA Neurology (Dr. Mark Quigg, MD). We're approaching Kickstarter launch with two consumer products — Komori Lite and Komori Plus, focused on position & movement trends and wellness — with the research-grade Komori Pro to follow, and we're actively seeking partnerships with epilepsy and autonomic-disorders foundations.

    Not a tracker. Not a wearable. Not a camera.

    The premise: families and patients with epilepsy and seizure-related risk need nightly visibility that doesn't require wearing something or pointing a camera at the bed.

    Not a tracker.

    Trackers count steps and stages. Komori watches the night and reports what actually happened — movement events, position changes, environmental conditions, plus respiratory motion on the Pro sensor suite. The full night, not a daily score.

    Not a wearable.

    Nothing on the body. Komori sits at the bedside and senses through bedding via 60 GHz radar plus ambient WiFi channel-state-information sensing. Compliance is not a problem when there is nothing to wear.

    Not a camera.

    No video. No images. The on-device microphone only records audio features — sound-event classifications; raw audio is not kept anywhere unless the user explicitly asks for it. Thermal sensing is at body-position resolution only; cannot show faces or features. The thermal feed is fully encrypted and no images are stored — only derived metrics persist. Privacy is a structural property of the architecture, not a procedural commitment.

    FOR THE PIPELINE AUDIENCE

    Where Komori fits.

    01

    Family-pilot programs (forming).

    Komori is preparing a family-pilot program for early-adopter families navigating SUDEP risk, nocturnal seizures, and family sleep concerns. Early-bird slots opening late June / July 2026. No prescription required, no clinical referral barrier — the device is in the family's hands and tunable to their patterns.

    02

    Seeking foundation partnerships.

    Komori is actively seeking partnerships with foundations across SUDEP-, sleep-, and autonomic-disorders advocacy. If your organization runs family-grant programs, awareness initiatives, or research-fund channels — let's talk about how Komori fits. No partnership is yet in place; this is an open invitation.

    03

    Three products: Komori Lite, Plus + Pro.

    Komori Lite and Komori Plus are the consumer-grade SKUs — focused on position & movement trends and wellness, Kickstarter launch, family-pilot eligible. Komori Pro is the research-grade SKU — full radar + thermal (encrypted feed; no images stored, only derived metrics) + audio (features-only; raw audio not kept unless the user explicitly asks) + ambient sensing, deployed under UVA IRB 302295 amendment with Dr. Mark Quigg, MD, as partnering clinical PI — coming later, beyond Kickstarter. Pro is what the STTR validation work expands; Lite and Plus are what reach families.

    04

    No-prescription accessibility (operating principle).

    Komori is committed to a no-prescription product model — wellness and nightly-awareness features available to any family, no insurance gatekeeping, no clinical referral required. This is a locked operating principle, not a launch-stage compromise.

    05

    Sister-site IRB recruitment.

    The NIH STTR in preparation builds toward a multi-site validation study. If you're affiliated with a pediatric or adult epilepsy center with vEEG capability — let's discuss what a sister-site collaboration could look like.

    WHAT WE PRESENTED

    Take the materials with you.

    Komori research brief — contactless, privacy-preserving nighttime monitoring built around the patterns you define
    Research brief

    Komori Research Brief

    A one-page overview of the platform, the UVA Neurology collaboration, and what we're looking for in research and foundation partners.

    Download PDF →

    Why Komori exists.

    I built Komori because my twin sons were born with Group B Strep and spent time in the NICU. My wife navigates a chronic sleep struggle. I have close friends with epilepsy.

    Each one of them — and millions of families like ours — deserves the kind of nightly visibility that doesn't require strapping something to a body or pointing a camera at a bed.

    Komori is the platform I wished existed when I was sitting in the NICU watching my sons on monitors I didn't understand, in a room without the privacy I wanted, with technology that couldn't tell me what I actually needed to know.

    — Dōvy Paukstys, Founder

    Built on real ground.

    PATENTS
    2 provisional patents
    63/999,180 · 64/066,136 · ~312 informal claims
    CLINICAL PARTNER
    UVA IRB 302295
    Amendment in motion · Dr. Mark Quigg, MD
    FEDERAL
    NIH STTR Phase I
    Phase I application · September 2026
    PUBLICATIONS
    IEEE manuscripts
    SPMB 2026 · Sensors Letters · in preparation
    LET'S CONNECT

    Discuss foundation partnership or family pilot.

    If you're a foundation rep, family advocate, patient organization, clinician, or industry partner — send an email and Dōvy will follow up within 48 hours.

    hello@komoricare.com

    Prefer to read more first?

    Visit komoricare.com →
    FDA disclosure

    Komori is a wellness product and is not a medical device. It is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for clinical care, prescribed treatment, or any safety protocol recommended by a healthcare provider. Always follow your clinician's guidance.

    Research-track collaborations referenced on this page (UVA IRB 302295 amendment, NIH STTR Phase I application in preparation) describe forward-looking research efforts and are not claims of current clearance, indication, or clinical performance.